Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
When AOD-9604 Fat Cell Targeting is Most Effective The AOD-9604 approach to fat cell targeting is particularly well-suited for individuals who have achieved good metabolic health through diet and exercise but struggle with stubborn fat deposits, those seeking selective fat loss without appetite suppression or systemic metabolic changes, athletes or active individuals who need to maintain training capacity and muscle mass during fat loss phases, individuals who cannot tolerate or are contraindicated for GLP-1 agonists or growth hormone therapy, and those seeking a research-backed, clinically-studied option with established safety data from human trials
Promotes overall well-being By reducing oxidative stress and inflammation, BPC-157 supports a balanced and healthy body
We take every precaution to ensure your safety, including cleaning the injection site with an antiseptic wipe to minimise the risk of infection
Currently, the phase 3 trial is expected to continue through the end of 2025 (4), and afterwards the drug application would be submitted to the Food and Drug Administration (FDA) for approval
US$ 29.22
US$ 26.24
US$ 29.32
US$ 20.23
US$ 20.39
US$ 24.57
US$ 29.34
US$ 22.97
